Shopping Cart
- Remove All
- Your shopping cart is currently empty
BCAT-IN-2 is an orally active and selective inhibitor of mitochondrial branched-chain aminotransferase (BCATm), inhibits BCATm and BCATc, and is used in obesity and dyslipidemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $50 | In Stock | |
5 mg | $80 | In Stock | |
10 mg | $121 | In Stock | |
25 mg | $221 | In Stock | |
50 mg | $298 | In Stock | |
1 mL x 10 mM (in DMSO) | $92 | In Stock |
Description | BCAT-IN-2 is an orally active and selective inhibitor of mitochondrial branched-chain aminotransferase (BCATm), inhibits BCATm and BCATc, and is used in obesity and dyslipidemia. |
Targets&IC50 | BCAT (rat, mitochondrial):7.39 (pIC50), BCAT (rat, cytosolic):6.6 (pIC50) |
In vitro | BCAT-IN-2 inhibits BCATm in primary human adipocytes, with a pIC50 of 6.5[1]. |
In vivo | BCAT-IN-2 (5 mg/kg, po; 1 mg/kg, iv) exhibits favorable pharmacokinetic parameters in mice[1]. |
Molecular Weight | 377.776 |
Formula | C17H14ClF2N5O |
Cas No. | 1800024-45-6 |
Smiles | CCCc1cc(=O)n2nc(NCc3c(F)cc(Cl)cc3F)c(C#N)c2[nH]1 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (79.41 mM), Sonification is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.